Trends in tuberculosis/human immunodeficiency virus comorbidity, United States, 1993-2004

Archives of Internal Medicine

Volumn 167, Issue 22, 2007, Pages 2443-2452

  Albalak, Rachel ^a   O'Brien, Richard J ^b   Kammerer, J Steve ^a   O'Brien, Sean M ^b,c   Marks, Suzanne M ^a   Castro, Kenneth G ^a   Moore, Marisa ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS   (Switzerland)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC PROCEDURE; DISEASE CONTROL; DISEASE COURSE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TUBERCULOSIS; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; TUBERCULOSIS; UNITED STATES;

EID: 37149000451     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.167.22.2443     Document Type: Article

References (40)

1. Burwen DR, Bloch AB, Griffin LD, Ciesielski CA, Stern HA, Onorato IM. National trends in the concurrence of tuberculosis and acquired immunodeficiency syndrome. Arch Intern Med. 1995;155(12):1281-1286.
2. Cantwell MF, Snider DE Jr, Cauthen GM, Onorato IM. Epidemiology of tuberculosis in the United States, 1983 through 1992. JAMA. 1994;272(7):535-539.
3. Rieder HL, Cauthen GM, Comstock GW, Snider DE. Epidemiology of tuberculosis in the United States. Epidemiol Rev. 1989;11:79-98.
4. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989;320(9):545-550.
5. Markowitz N, Hansen NI, Hopewell PC, et al. Incidence of tuberculosis in the United States among HIV-infected persons. Ann Intern Med. 1997;126(2):123-132.
6. Daley CL, Small PM, Schecter GF, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus: an analysis using restriction-fragment-length polymorphisms. N Engl J Med. 1992;326(4):231-235.
7. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis: a general review. Bibl Tuberc. 1970;26:28-106.
8. Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol. 1974;99(2):131-138.
9. Reported TB in the US, 2004. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/tb/surv/surv2005/default.htm. Accessed August 27, 2007.
10. Centers for Disease Control and Prevention (CDC). Update: trends in AIDS incidence, deaths, and prevalence - United States, 1996. MMWR Morb Mortal Wkly Rep. 1997;46(8):165-173.
11. McCray E, Onorato IM, Miller BI, Dondero TJ Jr, Bloch AB. Estimating HIV levels and trends among patients of tuberculosis clinics. Public Health Rep. 1990;105(2):135-140.
12. Centers for Disease Control and Prevention (CDC). Surveillance of tuberculosis and AIDS co-morbidity - Florida, 1981-1993. MMWR Morb Mortal Wkly Rep. 1996;45(2):38-41.
13. Centers for Disease Control and Prevention (CDC). Co-incidence of HIV/AIDS and tuberculosis - Chicago, 1982-1993. MMWR Morb Mortal Wkly Rep. 1995;44(11):227-231.
14. Little RJA, Rubin DB. Statistical Analysis With Missing Data. 2nd ed. Hoboken, NJ: Wiley Interscience; 2002.
15. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003;163(9):1009-1021.
16. Abouya YL, Beaumel A, Lucas S, et al. Pneumocystis carinii pneumonia: an uncommon cause of death in African patients with acquired immunodeficiency syndrome. Am Rev Respir Dis. 1992;145(3):617-620.
17. Ansari NA, Kombe AH, Kenyon TA, et al. Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997-1998. Int J Tuberc Lung Dis. 2002;6(1):55-63.
18. Centers for Disease Control and Prevention (CDC). Essential components of a tuberculosis prevention and control program: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWRMorb Mortal Wkly Rep. 1995;44(1)(RR-11):1-16.
19. Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for the Treatment of HIV. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents: recommendations of the Panel on Clinical Practices for Treatment of HIV. MMWR Morb Mortal Wkly Rep. 2002;51(RR-7):1-56.
20. Centers for Disease Control and Prevention (CDC). Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Morb Mortal Wkly Rep. 2000;49(1)(RR-6):1-54.
21. Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet. 2002;359(9323):2059-2064.
22. Santoro-Lopes G, de Pinho AM, Harrison LH, Schechter M. Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy. Clin Infect Dis. 2002;34(4):543-546.
23. Centers for Disease Control and Prevention (CDC). Racial disparities in tuberculosis - selected southeastern states, 1991-2002. MMWR Morb Mortal Wkly Rep. 2004;53(25):556-559.
24. Centers for Disease Control and Prevention (CDC). Reported TB in the US, 1989. Atlanta, GA: US Dept of Health and Human Services, Centers for Disease Control and Prevention; 1990.
25. Centers for Disease Control and Prevention (CDC). CDC wonder: AIDS public information data. Centers for Disease Control and Prevention Web site. http://wonder.cdc.gov/AIDSPublic.html. Accessed May 12, 2005.
26. Centers for Disease Control and Prevention (CDC). HIV/AIDS Surveillance Report, 2003. Vol 15. Atlanta, GA: US Dept of Health and Human Services, Centers for Disease Control and Prevention; 2004.
27. Bennett DE, Courval JM, Onorato IM, et al. Prevalence of TB Infection in the US Population 1999-2000. San Francisco, CA; American Public Health Association; 2003.
28. 28 CFR §549 (2005).
29. Spaulding A, Stephenson B, Macalino G, Ruby W, Clarke JG, Flanigan TP. Human immunodeficiency virus in correctional facilities: a review. Clin Infect Dis. 2002;35(3):305-312.
30. Scholten JN, Driver CR, Munsiff SS, et al. Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs. Clin Infect Dis. 2003;37(12):1686-1692.
31. Kong PM, Tapy J, Calixto P, et al. Skin-test screening and tuberculosis transmission among the homeless. Emerg Infect Dis. 2002;8(11):1280-1284.
32. Chaisson RE, Schecter GF, Theuer CP, Rutherford GW, Echenberg DF, Hopewell PC. Tuberculosis in patients with the acquired immunodeficiency syndrome: clinical features, response to therapy, and survival. Am Rev Respir Dis. 1987;136(3):570-574.
33. Burman WJ, Jones BE. Clinical and radiographic features of HIV-related tuberculosis. Semin Respir Infect. 2003;18(4):263-271.
34. Klein NC, Duncanson FP, Lenox TH III, Pitta A, Cohen SC, Wormser GP. Use of mycobacterial smears in the diagnosis of pulmonary tuberculosis in AIDS/ARC patients. Chest. 1989;95(6):1190-1192.
35. Leonard MK, Osterholt D, Kourbatova EV, Del Rio C, Wang W, Blumberg HM. How many sputum specimens are necessary to diagnose pulmonary tuberculosis? Am J Infect Control. 2005;33(1):58-61.
36. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City - turning the tide. N Engl J Med. 1995;333(4):229-233.
37. Burman W, Benator D, Vernon A, et al. Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis. Am J Respir Crit Care Med. 2006;173(3):350-356.
38. Ridzon R, Whitney CG, McKenna MT, et al. Factors for rifampin mono-resistant tuberculosis. Am J Respir Crit Care Med. 1998;157(6, pt 1):1881-1884.
39. Bock NN, McGowan JE, Blumberg HM. Few opportunities found for tuberculosis prevention among the urban poor. Int J Tuberc Lung Dis. 1998;2(2):124-129.
40. Graham NM, Galai N, Nelson KE, et al. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease. Arch Intern Med. 1996;156(8):889-894.